Annual Report 2022
With the consistent execution of our strategy, we have delivered on our financial targets in FY 2022: Growth has accelerated to double-digit organic growth in revenues and Adjusted EBITDA. We are steering Gerresheimer successfully through a dynamic environment and we will continue to leverage on business opportunities and to accelerate our profitable growth path.
16.2 %
Organic revenue growth
10.2 %
Organic growth
in Adjusted EBITDA
6.9 %
Organic growth
in Adjusted EPS
Our strategic investments from recent years are paying off, resulting in significantly higher growth rates and returns. Dietmar Siemssen CEO
We have accelerated our sustainable, profitable growth across all segments.
We are developing innovative solutions to improve patients' quality of life.
Focusing on highest quality is the cornerstone and driver of our growth and success.
We bring our values to life - every day. Together as a team, we continue to drive our success story going forward.
Thinking and acting sustainably is second nature to us.
